Date Field | Doc. No. | Description (Pages) |
---|
Apr 5, 2024 | N/A | CASE CLOSED (dlw) (Entered: 04/05/2024) (0) |
Apr 5, 2024 | 8 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (Attachments: # 1 Notice of Voluntary Dismissal)(as) (Entered: 04/05/2024) (0) |
Apr 4, 2024 | 7 | NOTICE of Voluntary Dismissal by American Regent, Inc. as to Without Prejudice (Viceconte, Christopher) (Entered: 04/04/2024) (2) |
Feb 28, 2024 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:24-cv-00248-MN, 1:24-cv-00249-MN (rjb) (Entered: 02/28/2024) (0) |
Feb 23, 2024 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Odin Pharmaceuticals, LLC, Somerset Pharma, LLC, Somerset Therapeutics, LLC ( Filing fee $ 405, receipt number ADEDC-4346189.) - filed by American Regent, Inc.. (Attachments: # 1 Exhibit 1, # 2 Civil Cover Sheet) (vfm) (Entered: 02/23/2024) (0) |
Feb 23, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 02/23/2024) (3) |
Feb 23, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/08/2024. Date of Expiration of Patent: 07/01/2041.Thirty Month Stay Deadline: 7/8/2026. (vfm) (Entered: 02/23/2024) (1) |
Feb 23, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (vfm) (Entered: 02/23/2024) (1) |
Feb 23, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc. and Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. Identifying Other Affiliate Daiichi Sankyo Company, Limited for American Regent, Inc. - filed by American Regent, Inc.. (vfm) (Entered: 02/23/2024) (2) |
Feb 23, 2024 | 6 | Summons Issued as to Odin Pharmaceuticals, LLC on 2/23/2024; Somerset Pharma, LLC on 2/23/2024; Somerset Therapeutics, LLC on 2/23/2024. (Attachments: # 1 Summons Issued Somerset Pharma, LLC, # 2 Summons Issued Odin Pharmaceuticals, LLC) (vfm) (Entered: 02/23/2024) (0) |